CEO's Presentation
Filed with ASX · · 15 pages · English
On 6ix: 6ix.com/news/ceos-presentation
Developing new insecticides derived from nature to achieve high impact worldwide. 19 November 2025 Tim Grogan Managing Director & CEO Important Notice & Disclaimer This presentation has been prepared by Bio-Gene Technology Limited (ASX:BGT) (the Company). This presentation is not, and should not be considered, an offer or invitation to apply for or purchase securities in the Company or as a recomm
Bio-Gene Technology Ltd. on 6ix
In the deck
Story so far
Earlier from Bio-Gene Technology
- Chair's Address to Shareholders
- Qcide receives organic listing status in USA
- Response to ASX Aware Letter
- Positive Flavocide Efficacy Results Presented
- Appendix 4E and 2025 Annual Report
Later from Bio-Gene Technology
- Bio-Gene Receives $519,500 R&D Tax Incentive
- U.S. Department of Defense Grant Programs Advance
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appendix 4D and Half-Year Accounts 31 December 2025
- Regulatory Development of Flavocide
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology